With 16 cancer drugs currently on the FDA’s drug shortage list, Jason Westin, MD, the director of Houston-based MD Anderson Cancer Center’s Lymphoma Clinical Research Program, section chief for Aggressive Lymphoma, told the Senate Finance Committee Dec…